3 Unstoppable Stocks to Buy in May
Prosper Junior Bakiny (Novo Nordisk): For the past several decades, Novo Nordisk has been a leader in the market for diabetes drugs. As of February 2022, the company held a 30.5% share of the diabetes care market, an increase from the 29.3% slice of the pie it had in February 2021. Novo Nordisk's dominance in this therapeutic area is one reason it has outperformed the broader market in each of the past one, five, 10, and 20 years.